Bone Biologics Announces $9 Million Private Placement Under Nasdaq Rules
Bone Biologics has announced a private placement offering up to $9 million, priced at-the-market under Nasdaq rules. The deal includes the sale of shares and warrants exercisable for additional shares over varying periods.